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OBJECTIVES This study examined the relationship between light-to-moderate alcohol consumption and
cause-specific mortality.
BACKGROUND Previous studies suggest a J-shaped relation between alcohol and total mortality in men. A
decrease in cardiovascular disease (CVD) mortality without a significant increase in other
causes of mortality may explain the overall risk reduction at light-to-moderate levels.
METHODS We conducted a prospective cohort study of 89,299 U.S. men from the Physicians’ Health
Study enrollment cohort who were 40 to 84 years old in 1982 and free of known myocardial
infarction, stroke, cancer or liver disease at baseline. Usual alcohol consumption was estimated
by a limited food frequency questionnaire.
RESULTS There were 3,216 deaths over 5.5 years of follow-up. We observed a U-shaped relationship
between alcohol consumption and total mortality. Compared with rarely/never drinkers,
consumers of 1, 2 to 4 and 5 to 6 drinks per week and 1 drink per day had significant
reductions in risk of death (multivariate relative risks [RRs] of 0.74, 0.77, 0.78 and 0.82,
respectively) with no overall benefit or harm detected at the $2 drinks per day level (RR 5
0.95; 95% confidence interval (CI), 0.79 to 1.14). The relationship with CVD mortality was
inverse or L-shaped with apparent risk reductions even in the highest category of $2 drinks
per day (RR 5 0.76; 95% CI, 0.57 to 1.01). We found no clear harm or benefit for total or
common site-specific cancers. For remaining other cancers, there was a nonsignificant 28%
increased risk for those consuming $2 drinks per day.
CONCLUSIONS These data support a U-shaped relation between alcohol and total mortality among
light-to-moderate drinking men. The U-shaped curve may reflect an inverse association for
CVD mortality, no association for common site-specific cancers and a possible positive
association for less common cancers. (J Am Coll Cardiol 2000;35:96–105) © 1999 by the
American College of Cardiology
Previous research suggests a J-shaped relationship be-
tween the level of alcohol consumption and total mortal-
ity in men. There is little debate over the causal relation-
ship between heavy alcohol intake and increased risk of
mortality (1–5), particularly deaths from liver disease,
cancers of the oropharynx and esophagus (6 –12) and
noncoronary cardiovascular disease (CVD) such as car-
diomyopathy and hemorrhagic stroke (3,4,13,14). The
reduction in total mortality at light-to-moderate levels
appears to be due to a reduction in CVD, without
significant increases in other causes of mortality (13–31). This
reduction is primarily manifested through a reduction in death
from coronary heart disease (CHD), a relationship which
appears to be inverse or L-shaped (32).
While there is general agreement that the mortality curve
is J-shaped, there is still some disagreement over its precise
nadir. Together, the uncertainty of the nadir, the known
risks from heavy alcohol consumption and a new public
interest in the potential benefits of light-to-moderate con-
sumption of alcohol make it even more important to know
more accurately the range of light-to-moderate alcohol
consumption where the benefits outweigh the risks.
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We therefore examined, prospectively, the relationship
between light-to-moderate alcohol consumption and mor-
tality in the Physicians’ Health Study enrollment cohort of
89,299 apparently healthy men. We also examined the
relationship of alcohol consumption and specific causes of
death, including cardiovascular diseases and various cancers,
in order to have a better understanding of the exact nature
of risks and benefits associated with light-to-moderate
alcohol consumption.
METHODS
Study population. The Physicians’ Health Study is a
randomized, double-blind, placebo-controlled trial testing
two primary-prevention hypotheses: 1) whether 325 mg of
aspirin taken every other day reduces mortality from CVD,
and 2) whether 50 mg of beta carotene taken on alternate
days decreases the incidence of cancer. Potentially eligible
participants in the Physicians’ Health Study were male
physicians residing in the U.S. In 1982 and 1983, letters of
invitation, informed consent forms and baseline question-
naires were mailed to the 261,248 eligible men who were
listed on an American Medical Association mailing tape. By
December 31, 1983, 112,528 physicians had responded to
the initial enrollment questionnaire. Most of these individ-
uals provided data on alcohol consumption, as well as other
baseline characteristics prior to December 31, 1983. These
analyses were confined to the 89,299 respondents age 40 to
84 years who provided alcohol data and had no prior history
of myocardial infarction (MI), stroke, cancer or liver disease
at baseline, including 21,876 randomized participants and
67,423 nonrandomized respondents.
Data collection. On the baseline questionnaire, physicians
reported their age and cardiovascular risk factors, including
cigarette smoking status (never, past, current—including
number of cigarettes smoked daily), use of antihypertensive
medication, systolic and diastolic blood pressure, history of
cholesterol lowering medications, cholesterol level, fre-
quency of vigorous exercise and personal history of angina
pectoris or diabetes mellitus. Body-mass index (kg/m2) was
calculated using self-reported weight and height.
Study participants also gave information regarding usual
alcohol intake in the previous year as part of a brief dietary
questionnaire. Exposure was categorized by responses to the
enrollment question, “How often do you usually consume
alcoholic beverages (beer, wine, liquor)?” Response options
were as follows: rarely/never, 1 to 3 times per month, 1 time
per week, 2 to 4 times per week, 5 to 6 times per week, daily
and $2 per day.
End points. In 1990, death certificates were obtained for
the respondents who died before the end of 1989, using the
National Death Index. The deaths were classified by trained
nosologists using the first revision of the Ninth Interna-
tional Classification of Diseases in conjunction with the
Automated Classification of Medical Entities Decision
Tables to manually select underlying cause of death. Cause
was assigned for the 3,216 deaths that accrued over the six
year period among the 89,299 respondents used in this
analysis. End points for this analysis included total death
and death due to CVD, MI, stroke, other cardiovascular
diseases, total cancer, colorectal cancer, prostate cancer, lung
cancer, pancreatic cancer, hematologic (lymphoma/
leukemia) cancer, other cancers, other (non-CVD, non-
cancer) causes, liver disease, suicide and violence/accident.
Sudden deaths were classified in the category of other CVD
death.
Statistical analysis. We computed means or proportions of
baseline risk factors for the reference group (rare and
nondrinkers) and the six reported levels of drinking. Pro-
portional hazards models were used to compute age-
adjusted and multivariate-adjusted relative risks (RRs) for
each intake category, as compared with the reference cate-
gory, for total mortality as well as for each specific cause of
death. The multivariate analyses were adjusted for age,
cigarette smoking (never, past, current), reported diabetes,
reported vigorous exercise and body-mass index (estimated
by reported weight and height). Models that included
reported history of angina and transient ischemic attacks to
the multivariate models did not materially alter the results.
We excluded hypertension (reported treatment or reported
systolic blood pressure) and reported treatment for hyper-
cholesterolemia because of the concern that they may be in
the causal pathway. However, in alternative analyses we
included these two risk factors, and results were not mate-
rially different from those observed for the full multivariate
models. We tested for linear trend in RR across the seven
alcohol consumption categories using an ordinal alcohol
variable. We also tested for the presence of a nonlinear
association by comparing log likelihoods of these linear
models with log likelihoods from models with categorized
alcohol consumption. For analyses of cause-specific deaths,
deaths other than the cause-specific death of interest were
censored at the time of death.
RESULTS
During a mean follow-up period of 5.46 years, 3,216 (3.6%)
of the 89,299 male physicians died. Table 1 displays major
causes of deaths as a percentage of the total deaths. Of the
3,216 total deaths, 1,450 (45.1%) died of CVD, including
514 (16.0%) from MI and 150 (4.7%) from stroke. All
cancers accounted for 944 (29.4%) of the deaths, including
Abbreviations and Acronyms
CHD 5 coronary heart disease
CI 5 confidence interval
CVD 5 cardiovascular disease
MI 5 myocardial infarction
RR 5 relative risk
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207 (6.4%) from lung cancer, 112 (3.5%) from colon cancer
and 78 (2.4%) from cancer of the prostate. There were 822
(25.6%) other deaths (non-CVD, non-cancer) which in-
cluded 35 (1.1%) deaths from liver disease; 311 (9.7%) from
violent, accidental, or suicidal death; 441 (13.7%) from
miscellaneous causes; and 35 (1.1%) from unknown causes.
Table 2 shows the baseline characteristics according to
level of alcohol intake. Overall, it was a group of light-to-
moderate alcohol consumers with 97% reported drinking
,2 drinks per day. Over 28% drank 1 to 3 drinks per month
or less, with 17% drinking rarely or never. Only 3% reported
drinking $2 drinks per day (the highest drinking category).
Compared with the reference group, those that consumed
$1 drink per day tended to be older, smoke more, have
higher total cholesterol and have an increased prevalence of
hypertension. Nondrinkers had higher rates of diabetes.
Total mortality. When compared with the reference group
of nondrinkers, we observed a statistically significant de-
crease in total mortality among light-to-moderate drinkers
of ,2 drinks per day after adjustment for age (Table 3).
Results were not materially altered after multivariate adjust-
ment. Figure 1A shows a U-shaped relationship between
alcohol consumption and total mortality after multivariate
adjustment (p for nonlinear association ,0.001). The rela-
tionship between alcohol and cardiovascular, cancer and
other deaths are shown in Figure 1B, 1C and 1D, respec-
tively. There was no overall benefit or harm detected among
those who consumed $2 drinks per day (RR 5 0.95; 95%
confidence interval [CI], 0.79 to 1.14).
Cardiovascular disease death. For the 1,450 deaths due to
CVD, the relationship between light-to-moderate alcohol
consumption and CVD mortality appeared to be inverse or
L-shaped (Fig. 1B) with trends toward reduced risk appar-
ent at 1 drink per week. As shown in Table 4, we observed
Table 1. Cause of Death Among the 89,299
Eligible Participants
Cause of Death Number % of Total Deaths
CVD 1,450 45.1
MI 514 16.0
Stroke 150 4.7
Other CVD 786 24.4
Cancer 944 29.4
Lung 207 6.4
Colon 112 3.5
Prostate 78 2.4
Pancreatic 85 2.6
Lymphoma/leukemia* 137 4.3
Other cancer† 325 10.1
Other 822 25.6
Liver 35 1.1
Violent, accident 189 5.9
Pulmonary 174 5.4
Suicide 122 3.8
Renal/genitourinary 36 1.1
Unknown 35 1.1
Miscellaneous 231 7.2
Total 3,216 100
*Lymphoma, 85 (2.6%); leukemia, 52 (1.6%); †other causes of cancer include: brain,
57 (1.8%); stomach, 33 (1.0%); bladder, 14 (0.4%); and melanoma, 18 (0.6%).
Table 2. Baseline Characteristics According to Level of Alcohol Consumption
Number of Drinks
Rarely/Never 1–3/Month 1/Week 2–4/Week 5–6/Week 1/Day >2/Day
Number (%) 15,166 (17.0) 10,308 (11.5) 12,506 (14.0) 18,555 (20.8) 9,975 (11.2) 19,963 (22.4) 2,826 (3.2)
Age 56.0 6 10.9* 53.2 6 10.3 53.1 6 10.1 53.2 6 9.7 53.9 6 9.6 57.6 6 10.4 57.8 6 10.2
Smoking (%)
Never 61.4 53.4 52.0 46.5 41.1 33.6 26.1
Past 28.7 34.8 37.6 42.9 47.2 50.7 51.1
Current 9.9 11.8 10.4 10.7 11.8 15.7 22.8
Cholesterol
History† (%) 7.7 8.5 8.0 7.7 7.9 9.1 11.9
mg/dl‡ 207 6 48 211 6 47 211 6 46 211 6 45 212 6 45 215 6 47 219 6 49
Hypertension
(%)§
18.1 16.6 15.2 15.8 16.7 22.3 27.1
Body mass index
kg/m2 25.0 6 3.4 25.1 6 3.4 25.1 6 3.2 25.0 6 3.0 24.8 6 2.9 24.8 6 2.9 25.2 6 3.2
.26.5¶ (%) 26.3 26.8 27.2 24.5 22.7 22.3 29.3
Exercise $1/week
(%)
64.7 63.2 69.9 74.2 75.3 72.5 63.3
Angina (%) 3.5 2.8 2.8 2.6 2.5 3.6 3.6
Diabetes (%) 5.4 3.9 2.8 2.3 2.2 2.7 2.8
*For continuous variables means 6 standard deviation are presented. †History of treatment for hypercholesterolemia (n 5 76,846). ‡Reported plasma level (n 5 33,238).
§Self-reported systolic blood pressure $160 mm Hg, diastolic blood pressure $95 mm Hg or reported treatment for hypertension. ¶Highest quartile.
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a borderline or significant 19% to 26% reduction in cardio-
vascular death after adjustment for available risk factors
among drinkers who consumed $1 drink per week (p for
linear trend ,0.001). Of the CVD deaths, 514 were
attributed to MI. As for CVD deaths, the relationship
between alcohol consumption and death from MI was
L-shaped (Table 4) with significant reductions in risk of
32% to 47% among those who consumed $1 drink per week
or more (p for linear trend ,0.001). For stroke, we observed
no significant increase or decrease in any category; however,
there was a nonsignificant suggestion of reduced risk of fatal
stroke among the light drinkers—monthly to 2 to 4 drinks
per week (Table 4). Other causes of CVD death accounted
for 786 of the total deaths. There was a nonsignificant trend
across categories toward lower risk of other CVD death
after multivariate adjustment (p 5 0.12).
Cancer deaths. In total, 944 deaths due to various cancers
accrued. The age-adjusted RR for total cancer death (Table
5) was significantly increased (RR 5 1.53; 95% CI, 1.15 to
2.05) at the highest drinking level; however, a large propor-
tion of the excess risk appeared to be due to confounding by
smoking. When the relationship was adjusted for available
potential confounders, excluding smoking, the RR was not
materially altered (RR 5 1.54; 95% CI, 1.14 to 2.08), but
after further adjustment for smoking the RR was attenuated
and not significant (RR 5 1.18; 95% CI, 0.87 to 1.62).
After multivariate adjustment, no significant increases or
decreases in risk of lung, colon, prostate, pancreatic or
hematologic (lymphoma or leukemia) were apparent in any
drinking category. We observed an increase in the age-
adjusted risk of lung cancer among those who consumed $2
drinks per day (RR 5 2.53; 95% CI, 1.47 to 4.35) which
was explained largely by smoking status (multivariate RR 5
1.30; 95% CI, 0.72 to 2.34). Lung and prostate cancer
tended to be lower among lighter drinkers and pancreatic
cancer rates tended to be higher among those in the $2
drinks per day category, but none of these associations was
statistically significant. There was no increased risk for the
other cancers at intake ,14 drinks per week after multivar-
iate adjustment (Table 5). For the remaining group of less
common cancers, an increased risk was suggested (RR 5
1.28; 95% CI, 0.74 to 2.21) among those who drank $2
drinks per day. The test for linear trend, however, was not
significant (p for trend 5 0.92). This category included
stomach, bladder, brain, esophageal and other less common
cancers.
All other deaths. The remaining causes of mortality ac-
counted for 822 deaths. There were significantly decreased
risks of other (non-cancer and non-CVD) deaths among
those who consumed ,7 drinks per week (Table 6) (p for
nonlinear association 5 0.002). These deaths included
violent/accidental, suicide, pulmonary, renal/genitourinary
and gastrointestinal hemorrhage deaths. Alcohol intake was
not significantly associated with the 189 violent or acciden-
tal deaths or with the 122 suicides in the age-adjusted orTa
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multivariate models. While rates of violent death were
slightly reduced and rates of suicide were slightly increased
in the highest drinking category, these estimates were based
on only seven violent deaths and suicides; thus confidence
bounds were wide. Alcohol intake of 1 to 6 drinks per week
had a nonsignificant inverse association with pulmonary
death. Alcohol was not significantly associated with the 36
deaths attributed to renal/genitourinary causes or the 30
Figure 1. A. Relative risk of total mortality by alcohol consumption category after multivariate adjustment. B. Relative risk of CVD
mortality by alcohol consumption category after multivariate adjustment. C. Relative risk of cancer mortality by alcohol consumption
category after multivariate adjustment. D. Relative risk of other mortality by alcohol consumption category after multivariate adjustment.
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deaths attributed to liver disease. However, there was a
nonsignificant trend toward increased risk at both the 1 and
$2 drinks per day categories.
DISCUSSION
In this prospective cohort study among 89,299 U.S. male
physicians there was a U-shaped relationship between light-
to-moderate alcohol intake and risk of total mortality with
a decreased risk of total mortality of up to 26% among those
who consumed 1 to ,14 drinks per week. There was no
significant overall increased risk of death among those who
consumed $2 drinks per day in this cohort of moderate
drinkers. The U-shaped mortality curve observed in this
study among light-to-moderate drinkers is consistent with
the previous studies (1–5, 31).
Alcohol and total mortality. The U-shaped relationship
between alcohol and total mortality is the result of the
summation of the disease-specific curves. The nadir of the
curves results from lower risk of CVD death (and perhaps
non-cancer and non-CVD causes of death) among lighter
drinkers without any increased risk in cancer. At $2 drinks
per day, the CVD benefits may begin to be offset by
increasing risk of some of the less common cancers. The
individual CVD, cancer and other death curves derived
from this cohort may help predict the overall mortality curve
for a given population by weighing each curve according to
the cause specific mortality distribution and then combining
the weighted curves into a single mortality curve.
The precise location of the nadir varies from study to
study. Our results showed similar reductions in mortality
between 1 and 7 drinks per week with a slightly greater
reduction in all cause mortality at 1 drink per week. This is
consistent with two recent studies, one in Danish adults and
the other in British male physicians with nadirs between 1
to 6 drinks per week and 5 to 9 drinks per week, respectively
(32, 33). However, the drinking level associated with the
lowest total mortality varies widely from as low as 1 drink
per week to 5 drinks per day (34, 35). The exact location of
the nadir may vary depending on the distribution of cause-
specific mortality or differing drinking patterns in each study
population, as well as methodologic differences between
studies.
Alcohol and cause-specific mortality. In this study, the
risk reduction in CVD mortality was primarily driven by a
significant 32% to 47% reduction in MI that persisted in the
highest drinking category. These findings are consistent
with a recent meta-analysis suggesting an L-shaped effect of
moderate alcohol on risk of nonfatal MI (36). In that study
the reduction in risk began at 1⁄2 drink per day and reached
maximal benefit at 1 drink per day. There was a nonsignif-
icant suggestion of lower stroke risk in the present analysis
among the light drinkers—between 1 to 4 drinks per week.
Prior reports in both men and women have suggested that
light alcohol consumption may decrease the risk of stroke,Ta
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but that at higher levels of consumption there may be an
increased risk of stroke (23, 37–39). This apparent reduc-
tion at light drinking levels, if confirmed in other studies,
may be explained by different effects of alcohol on ischemic
and hemorrhagic strokes.
Among light-to-moderate drinkers, there was no clear
association with total cancer mortality. None of the more
common individual cancers among men—lung, colon, pros-
tate, lymphoma or leukemia—was clearly associated with
alcohol intake after controlling for potential confounders.
These results support prior findings of little or no increased
overall cancer risk among male, light-to-moderate drinkers
(6). The apparent increase in age-adjusted lung cancer risk
among those consuming $2 drinks per day appeared to be
due entirely to confounding by cigarette smoking. There
was a suggestion of decreased risk for prostate and lung
cancer among lighter drinkers and increased risk of pancre-
atic cancer among those who drank $2 drinks per day, but
this study was underpowered to draw any definitive conclu-
sions. Only in the remainder of cause-specific cancer
deaths—“other cancers”—was there a borderline nonsignif-
icant increased risk of death among those drinking $2
drinks per day. This group includes less common malignan-
cies including cancers of the stomach, oropharynx and
esophagus which have previously been associated with
alcohol use.
The explanation for the U-shaped relationship between
drinking and all “other causes” (non-cancer, non-CVD) of
death is not entirely clear. This category includes a wide
variety of specific causes of death with potentially disparate
associations with alcohol, and the small numbers of end
points for many causes yielded imprecise estimates. Many of
the deaths due to unknown or miscellaneous causes (n 5
266) may have been due to ischemic heart disease. This
misclassification could explain a portion of the risk reduc-
tion. Also, unmeasured variables may confound the rela-
tionship between alcohol and risk of “other causes” of death,
biasing our risk estimates. It is also possible that comorbid
CHD could lead to increased mortality due to other causes;
thus reductions in CHD associated with alcohol intake
could result in lower mortality from other causes. There was
no clear association for traumatic (violent/accidental and
suicide) deaths among light-to-moderate drinkers. While
there is a clear association between heavy drinking and acute
alcohol intoxication and traumatic death (40), light drinkers
are not reported to be at increased risk of fatal injury
(41–44). The increased risk of traumatic death associated
with alcohol is reported to be predominantly among young
men (45) with high peak blood alcohol levels (43). Given
the age of our population and a cohort consisting almost
entirely of light-to-moderate drinkers, we anticipated no
increased risk of traumatic death and alcohol. Among other
causes of death we found a suggestive inverse association
between alcohol and pulmonary death at light-to-moderate
levels of intake, but since this was not an a priori hypothesis
it requires further exploration. Liver deaths, which were aTa
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part of the other causes category, showed increased associ-
ation with alcohol consumption at $1 drink per day though
these estimates are based on only a few cases. The small
numbers of deaths in this category possibly reflect the small
number of heavy drinkers in this group of male physicians
and the relative infrequency of deaths due to liver disease in
the U.S. population. The limited number of renal or
genitourinary deaths also hindered our ability to detect an
association.
Possible limitations. Several potential limitations of this
study are worth discussion. First, this study relied on
self-reported data. If there were a systematic underestima-
tion of alcohol consumption, this may artificially shift the
reported associations towards lower drinking categories and
lead to underestimation of the nadir of the alcohol-mortality
relationship. However, studies, including those of health
professionals, have found self-reporting to be reliable for
general classification of drinking habits (46–48). Second,
our study used a single measure of alcohol consumption at
one point in time. Since intake may change over time, this
could also lead to some misclassification; however, drinking
patterns among middle-aged and older individuals tend to
be stable over time (49). Third, our study requested infor-
mation on average intake; thus, we were unable to explore
relationships by drinking pattern. The risks and benefits
may be quite different for the individual who has 1 drink per
day with dinner and the person who has seven drinks on
Friday night, despite the two individuals sharing the same
average daily intake. Fourth, the questionnaire used did not
allow us to identify heavy drinkers. The highest drinking
category was $2 drinks per day. While we feel that the
number of heavy drinkers was likely to be low given the
overall distribution of drinking in this cohort, it would have
been preferable to exclude heavy drinkers from this drinking
category. It remains possible that some of the apparent
excess risk observed in this highest category may have been
confined to heavier drinkers. Fifth, we did not distinguish
between the types of beverage consumed and, thus, could
not compare risks and benefits of wine, beer or liquor
consumption. Sixth, Shaper et al. (50) have suggested that
the reduction in CVD risk among drinkers could be in part
explained by an excess risk among those in the nondrinking
categories who stopped drinking because of underlying
disease. While we were unable to exclude recent exdrinkers,
we excluded anyone who reported a history of MI, stroke,
cancer or liver disease. Further, there was no material
difference in rates of various coronary risk factors between
rare/never drinkers or light drinkers (1 to 3 drinks per
month). Most recent studies have excluded recent exdrink-
ers and have reported similar results (22, 51, 52). Finally,
residual confounding by unmeasured variables is likely
small, since adjustment for the known major confounders
had little affect on the RRs.
We cannot add to the debate regarding the risks and
benefits among women, particularly given their lower rates
of CHD (53), increased risk of breast cancer (54, 55) and
potentially increased susceptibility to alcoholic liver disease
(56, 57). Recently, Fuchs et al. (58) found a similar
U-shaped relation between light-to-moderate alcohol con-
sumption and mortality among women in the Nurses’
Health Study, which was largely due to a decrease in CVD
at light-to-moderate levels (1.5 to 29.9 g per day [1 to 21⁄2
drinks per day]) with an increase in breast cancer at higher
levels ($30 g per day [$21⁄2 drinks per day]). Overall, we
analyzed, after exclusions, a group of relatively healthy men
with a higher level of education, a higher socioeconomic
status and easier access to health care than the general
population. If, in fact, this population of men was healthier
than the general population, then our findings argue against
other studies that suggest the benefit of moderate alcohol
consumption is only present among those sicker populations
(50, 59). It may be possible to generalize these findings to
other populations by summing disease specific curves
weighted by the cause-specific death distribution for any
given population.
Conclusions. In summary, this study reveals the complex
effects of alcohol consumption on various chronic diseases as
reflected in the overall U-shaped relationship between
light-to-moderate alcohol consumption and total mortality
in men. Reductions in risk of death among light drinkers are
largely due to lower risk of CVD and no clear increases in
cancer; however, the CVD benefits may begin to be offset by
increasing risk of some of the less common cancers at a level
of $2 drinks per day. In addition to these effects revealed in
our study, alcohol has many other proposed metabolic,
physiologic and psychologic effects on the individual as well
as many societal repercussions related to heavier drinking.
Alcohol-related deaths are still a major cause of preventable
death in this country. Given the complex nature of the
relationship of alcohol with various diseases, alcohol con-
sumption can neither be viewed as a primary preventive
strategy nor should it necessarily be viewed as an unhealthy
behavior. A discussion of alcohol intake should be a part of
routine preventive counseling, but any individual or public
health recommendations must consider the totality of evi-
dence, which includes deleterious metabolic, physiologic
and psychologic consequences.
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